RJA
SGRY icon

Raymond James & Associates’s Surgery Partners SGRY Stock Holding History

Raymond James & Associates’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.94M Sell
60,039
-8,833
-13% -$261K ﹤0.01% 2247
2024
Q2 		$1.64M Buy
68,872
+4,370
+7% +$112K ﹤0.01% 2281
2024
Q1 		$1.92M Buy
64,502
+16,814
+35% +$526K ﹤0.01% 2181
2023
Q4 		$1.53M Sell
47,688
-13,500
-22% -$392K ﹤0.01% 2255
2023
Q3 		$1.79M Buy
61,188
+736
+1% +$26.5K ﹤0.01% 2087
2023
Q2 		$2.72M Sell
60,452
-1,593
-3% -$60.8K ﹤0.01% 1875
2023
Q1 		$2.14M Sell
62,045
-1,444
-2% -$46.9K ﹤0.01% 1993
2022
Q4 		$1.77M Buy
63,489
+24,644
+63% +$653K ﹤0.01% 2070
2022
Q3 		$909K Buy
38,845
+348
+0.9% +$11.1K ﹤0.01% 2464
2022
Q2 		$1.11M Buy
38,497
+797
+2% +$34.8K ﹤0.01% 2363
2022
Q1 		$2.08M Buy
37,700
+2,758
+8% +$136K ﹤0.01% 2104
2021
Q4 		$1.87M Buy
34,942
+1,149
+3% +$53.3K ﹤0.01% 2226
2021
Q3 		$1.43M Sell
33,793
-7,286
-18% -$372K ﹤0.01% 2342
2021
Q2 		$2.74M Buy
41,079
+7,130
+21% +$387K ﹤0.01% 1882
2021
Q1 		$1.5M Buy
+33,949
New +$1.26M ﹤0.01% 2223
2020
Q1 		– Sell
-14,152
Closed -$222K – 3692
2019
Q4 		$222K Hold
14,152
– – ﹤0.01% 3281
2019
Q3 		$105K Buy
+14,152
New +$101K ﹤0.01% 3384
2018
Q3 		– Sell
-12,445
Closed -$185K – 3704
2018
Q2 		$185K Buy
+12,445
New +$209K ﹤0.01% 3285
2018
Q1 		– Sell
-45,509
Closed -$551K – 3578
2017
Q4 		$551K Sell
45,509
-37,602
-45% -$359K ﹤0.01% 2479
2017
Q3 		$860K Sell
83,111
-61,310
-42% -$877K ﹤0.01% 2187
2017
Q2 		$3.29M Sell
144,421
-10,612
-7% -$218K 0.01% 1261
2017
Q1 		$3.02M Sell
155,033
-27,958
-15% -$543K 0.01% 1285
2016
Q4 		$2.9M Buy
182,991
+62,905
+52% +$1.05M 0.01% 1264
2016
Q3 		$2.43M Buy
120,086
+76,672
+177% +$1.41M 0.01% 1342
2016
Q2 		$777K Buy
43,414
+7,847
+22% +$117K ﹤0.01% 1884
2016
Q1 		$472K Sell
35,567
-515
-1% -$7.96K ﹤0.01% 2074
2015
Q4 		$739K Buy
+36,082
New +$689K ﹤0.01% 1797

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James & Associates's SGRY Position: Q3 2024 in Review

Raymond James & Associates reduced its Surgery Partners (SGRY) stake by 13% in Q3 2024, selling an estimated $261K and leaving 60,039 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2247.

Raymond James & Associates first reported a position in SGRY in Q4 2015 and has held it in 27 quarters since. The position peaked at $3.29M in Q2 2017. 183 funds tracked by Wall St. Rank hold SGRY as of Q3 2024.

  • Raymond James & Associates held 60,039 shares of Surgery Partners worth $1.94M as of Q3 2024.
  • Raymond James & Associates sold 8,833 Surgery Partners shares in Q3 2024, an estimated $261K.
  • Surgery Partners made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2247 holding.
  • Raymond James & Associates first reported a position in Surgery Partners in Q4 2015 and has held it in 27 quarters since.
  • Raymond James & Associates's Surgery Partners position peaked at $3.29M in Q2 2017.
  • 183 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.